drugset / Trial / NCT02486289

Pilot Proof of Concept Study of NBMI Treatment of Mercury Intoxication

NCT02486289 ↗

Phase 2 Completed 36 enrolled EmeraMed NBMI Science AB · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A randomized, placebo controlled, double blind proof of concept study of NBMI in treatment of mercury intoxication.

Timeline

Start
2015-08
Primary completion
2016-01
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Emeramide Small molecule 100 mg Oral
Subject Emeramide Small molecule 300 mg Oral

Indications